Investors / Ireland / Seroba Life Sciences
Seroba Life Sciences
Venture capital · Dublin, Ireland · Europe
Seroba is a European life sciences venture capital firm that backs innovations in biotech and medtech. It works with entrepreneurs to build businesses around science, with offices in Dublin, Milan and Paris.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechmedtechtherapeuticsmedical devices
Your fit with Seroba Life Sciences
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsSeroba Life Sciences lists 22 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series B, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). It invests most often alongside Kurma Partners, BioGeneration Ventures and Aperture Venture Partners.
Counts come from funding rounds that name Seroba Life Sciences, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Seroba Life Sciences' whole history. Rounds on record name 1 company; its own site lists 22. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundSeroba Life Sciences does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 100% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 1 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 55th | 22 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 62th | 5% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 88th | 7 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Kurma Partners | 4 |
| BioGeneration Ventures | 3 |
| Aperture Venture Partners | 2 |
| Cambridge Innovation Capital | 2 |
| Global BioAccess Fund | 2 |
| Jeito Capital | 2 |
| Lumira Ventures | 2 |
| V-Bio Ventures | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers22100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Seroba Life Sciences head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with Seroba Life Sciences| Date | Company | Stage |
|---|---|---|
| 5 Oct 2023 | Series B |
Round details for Seroba Life Sciences
Amounts, full round histories and every co-investor in Seroba Life Sciences' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
22 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Alveus Therapeutics develops treatments for obesity and weight loss maintenance | Healthcare & Biotech | Portfolio page | ||
| Artica Therapeutics is developing novel therapies for patients suffering from severe autoimmune and inflammatory disorders | Healthcare & Biotech | Portfolio page | ||
| Azafaros develops treatments for rare neurological diseases, including lysosomal storage disorders. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare ocular and CNS diseases. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Deciphex is building a global network of AI empowered pathologists, ensuring accessible, innovative pathology services that improve patient outcomes. | Healthcare & Biotech | Portfolio page | ||
| Endotronix makes a system for remote management of heart failure | Healthcare & Biotech | Portfolio page | ||
| Fusion Pharmaceuticals develops targeted alpha therapeutics for precision medicine to treat cancers | Healthcare & Biotech | Portfolio page | ||
| Loci Orthopaedics is a medical device company specialising in the development of orthopaedic technologies to meet unmet clinical needs in the orthopaedics extremities space. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Palliare develops and sells medical equipment, including insufflators for laparoscopic surgery and therapeutic endoscopy. | Healthcare & Biotech | Portfolio page | ||
| Perfuze aims to improve patient outcomes with advanced superbore aspiration technology that simplifies access and clot removal. | Healthcare & Biotech | Portfolio page | ||
| The company produces and sells products containing bacteria that occur naturally in the human gut | Healthcare & Biotech | Portfolio page | ||
| Quanta develops and provides hemodialysis technology for kidney care | Healthcare & Biotech | Portfolio page | ||
| Ryme Medical is developing a catheter-based therapy to reduce symptoms and improve long-term outcomes in patients with Chronic Obstructive Pulmonary Disease (COPD). | Healthcare & Biotech | Portfolio page | ||
| ShiraTronics develops a neuromodulation device to treat chronic migraine | Healthcare & Biotech | Portfolio page | ||
| Shorla Oncology develops and commercialize innovative oncology drugs | Healthcare & Biotech | Oct 2023Series B | Page + round | |
| Sibylla Biotech develops small molecule drug candidates that target proteins before they become undruggable using its proprietary technology platform. | Healthcare & Biotech | Portfolio page | ||
| STORM Therapeutics develops and evaluates RNA modifying enzyme inhibitors for use in human clinical trials. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- serobavc.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 5 Oct 2023
- Companies checked
- 22
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Seroba Life Sciences' profile as data
Pull Seroba Life Sciences' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/serobavc.com
# also
GET /v1/firms/serobavc.com/portfolio
GET /v1/firms/serobavc.com/coinvestors
GET /v1/firms/serobavc.com/news